GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Other Stockholders Equity

Diamyd Medical AB (OSTO:DMYD B) Other Stockholders Equity : kr0.20 Mil (As of Feb. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Other Stockholders Equity?

Diamyd Medical AB's Other Stockholders Equity for the quarter that ended in Feb. 2025 was kr0.20 Mil.

Diamyd Medical AB's quarterly Other Stockholders Equity increased from Aug. 2024 (kr0.20 Mil) to Nov. 2024 (kr0.20 Mil) but then declined from Nov. 2024 (kr0.20 Mil) to Feb. 2025 (kr0.20 Mil).

Diamyd Medical AB's annual Other Stockholders Equity increased from Aug. 2022 (kr0.20 Mil) to Aug. 2023 (kr0.20 Mil) but then declined from Aug. 2023 (kr0.20 Mil) to Aug. 2024 (kr0.20 Mil).

Diamyd Medical AB Other Stockholders Equity Historical Data

The historical data trend for Diamyd Medical AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Other Stockholders Equity Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.20 0.20 0.20 0.20

Diamyd Medical AB Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.20 0.20 0.20

Diamyd Medical AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Diamyd Medical AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Other Stockholders Equity
Comparable Companies
XSAT:HAMLET B OSTO:IBT B OSTO:SYNACT OSTO:SANION OSTO:MAGLE OSTO:FLUO OSTO:ONCO OSTO:CANTA OSTO:INIT OSTO:IRLAB A VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
DYMDF:USA DMN:Germany
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Website
https://www.diamyd.com
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines